Oral care composition
Disclosed are oral care compositions and the use of such oral care compositions for treating conditions caused by biofilm formation. Also disclosed are methods for inhibiting biofilm formation and/or degrading biofilm. The oral care composition includes a sesquiterpenoid and an antimicrobial agent, in which the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity.
1. An oral care composition comprising a sesquiterpenoid and an antimicrobial agent, wherein the sesquiterpenoid and the antimicrobial agent are present in an amount effective to inhibit and/or degrade a biofilm in the oral cavity, wherein the sesquiterpenoid is bisabolol, and wherein the antimicrobial agent is selected from magnolol, honokiol, propyl honokiol and mixtures thereof.
2. The oral care composition according to claim 1 wherein the sesquiterpenoid is present in the composition at a concentration of up to 1% w/w.
3. The oral care composition according to claim 1 wherein the bisabolol is present in the composition at a concentration of 0.025 to 0.075% w/w.
4. An oral care composition according to claim 1 , further comprising at least one of zinc chloride, zinc lactate, and zinc citrate.
5. An oral care composition according to claim 1 wherein the antimicrobial agent is magnolol.
6. An oral care composition according to claim 3 , wherein the sesquiterpenoid has a BEC 50 in the presence of the antimicrobial agent of 25% or less compared to the BEC 50 of the sesquiterpenoid in the absence of the antimicrobial agent.
7. An oral care composition according to claim 6 , wherein the sesquiterpenoid is bisabolol, and the bisabolol has a BEC 50 of 20 ppm to 30 ppm.
8. An oral care composition according to claim 6 , wherein the antimicrobial agent has a BEC 50 in the presence of sesquiterpenoid 75% or less compared to the BEC 50 of the antimicrobial agent not in the presence of the sesquiterpenoid.
9. An oral care composition according to claim 8 , wherein the antimicrobial agent has a BEC 50 in the presence of sesquiterpenoid 50% or less compared to the BEC 50 of the antimicrobial agent not in the presence of sesquiterpenoid.
10. An oral care composition according to claim 1 , wherein the composition further comprises one or more agents selected from an anti-plaque agent, a whitening agent, a sweetening agent, a cleaning agent and a flavouring agent.
11. An oral care composition according to claim 1 , wherein the composition comprises an orally acceptable carrier for a toothpaste, a dental cream, a mouthwash, a chewing gum or a denture adhesive.
12. An oral care composition according to claim 1 , for use as a medicament.
13. A composition comprising bisabolol and an antimicrobial agent for the treatment or prevention of a condition caused by biofilm formation.
14. A composition according to claim 13 , wherein the condition is in the oral cavity.
15. A composition according to claim 14 , wherein the condition is selected from dental plaque, tooth decay: periodontal disease, halitosis, or gingivitis.
16. A method of inhibiting biofilm formation and/or degrading a biofilm in a subject comprising administering to the subject a composition according to claim 1 .
17. A method according to claim 16 , wherein the composition is applied to an oral cavity.
18. A method according to claim 17 , wherein the method prevents or treats a condition caused by biofilm formation in the oral cavity.
19. A method according to claim 16 , wherein the condition is selected from dental plaque, tooth decay, periodontal disease, halitosis, or gingivitis.
20. A method according to claim 16 , wherein the biofilm is formed from a single species of bacteria.
21. A method according to claim 16 , wherein the biofilm is formed from a plurality of species of bacteria.
22. A method according to claim 16 , wherein the biofilm is formed from one or more bacteria selected from A. viscosus, Lactobacillus casei, Streptococcus oralis, Fusobacterium nucleatum and Veillonella parvula.